FinRadar.ai retweeted
$PHVS
Bullish chart on daily but no position!
@StuckInStock
FinRadar.ai retweeted
$ALMS
Insider buying here!
276K shares at $5.25!
many catalyst in Q1 2026!
$ALMS bullish technical signal triggered a few days ago. Heavy biotech funds interest as well, and key catalysts coming in psoriasis and Lupus in 2026
Hope all is well.
finradar.ai/stock-research/?…
FinRadar.ai retweeted
Piper Sandler reitd $ATYR OW/$20, after🗣️w/ MGMT/learned add'l tidbits that=PS's confidence in efzofitimod's value prop—a stat sig separation in avg daily OCS dose reduction would be a clear win as it would lower the cumulative burden of steroids (as echoed by FDA's perspective):
FinRadar.ai retweeted
$TSVT
Decent chart , had approval with $BMY in April, Decent insider buying by Casdin capital 4.9 and 5.1, baker bros in!
CC: @StuckInStock
FinRadar.ai retweeted
$SAVA Why search for a new CEO? Just admit the whole company was based on a fraud, dissolve the company and move on...
Remi Barbier resigns as President and CEO and from the Board of Directors.
Lindsay Burns, Ph.D., SVP, Neuroscience, at Cassava is also to step down from her role with the Company, effective immediately.
FinRadar.ai retweeted
Stanley Druckenmiller on Powell: "Don't go on 60 Minutes, you're not a rock star."
FinRadar.ai retweeted
$VTYX $100M PIPE $8.95
FinRadar.ai retweeted
Replying to @StuckInStock
All these medtech stocks acting like Ozempic is going to cure every illness. It’s getting ridiculous
FinRadar.ai retweeted
$AVRO AVROBIO to Explore Strategic Alternatives
FinRadar.ai retweeted
Need more fertilizer to make this grow. $CORN.
FinRadar.ai retweeted
$TCRX baker bros!
New SC 13D/A from BAKER BROS. ADVISORS LP concerning $TCRX. See details at tinyurl.com/2olzrun3
FinRadar.ai retweeted
Cantor $PDSB PT25 interim data showed an est 12-month survival rate of 87% (PFS) of 10.4 months encouraging given poor prognosis these patients face. remain encouraged by safety profile of PDS0101 in combination with KEYTRUDA, with only 8% of patients experiencing a Grade 3AE
FinRadar.ai retweeted
$ORTX (L)
Orchard Therapeutics: MLD Opportunity Could Be Larger Than Initial Estimates
seekingalpha.com/article/459…































